We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
DOP020 Serum micro- and nano-plastic burden as a risk marker for Crohn’s disease progression: a multi-omics discovery of gut microbiome–metabolite perturbations
Summary
Researchers measured serum levels of 11 micro- and nanoplastic polymers in 241 Crohn's disease patients and 43 healthy controls, then followed them prospectively for disease progression. The study found that Crohn's patients had significantly higher serum microplastic levels than healthy controls, and that higher baseline microplastic burden was associated with increased risk of disease progression. Multi-omics analysis revealed that microplastic levels correlated with specific gut microbiome and metabolite changes that may contribute to disease worsening.
Abstract Background Up to half of patients with Crohn’s disease (CD) progress to disabling complications despite advanced therapies, with environmental exposures implicated as modifiers of disease course1. Micro- and nano-plastics (MNPs) are newly recognized ubiquitous contaminants capable of disrupting gut barrier and immune function in preclinical models2, yet no prospective human data link systemic MNP levels and its microbiome–metabolite correlates to CD progression. Methods In this two-center prospective study, serum levels of 11 MNP polymers were quantified using pyrolysis–gas chromatography–mass spectrometry in 241 CD patients and 43 healthy controls (HCs). Cross-sectional analyses compared serum MNP burden between CD and HCs and evaluated its associations with disease activity, behavior (B1 vs B2/B3), and inflammatory markers. CD patients with B1 behavior and no prior intestinal resection (n = 167) was prospectively followed (mean, 27.0±10.3 months) for composite progression outcomes. Multivariable Cox models assessed the association of baseline MNP burden with progression, adjusting for clinical risk factors. A multi-omics subset underwent fecal 16S/metagenomic sequencing and serum/fecal metabolomics to identify MNP-linked microbiome–metabolite signatures. Network and mediation analyses explored potential pathways in MNP-related progression. Results Serum MNP levels were significantly higher in CD than HCs (total: 90.7±33.7 vs 32.8±12.5 µg/g, p<0.001), with PS, PE, PP, PVC and PA66 detected in all participants. Elevated total MNPs correlated with more severe endoscopic/MRE inflammation (r≈0.15–0.45, p<0.05) and with stricturing/penetrating behavior (B2/B3 vs B1; OR 2.65, 95%CI 1.41–5.11). During follow-up, high total MNP exposure was associated with more frequent progression (45.7% vs 25.8%) and shorter progression-free survival (log-rank p = 0.011). Total MNPs independently increased progression risk (HR 2.95, 95%CI 1.57–5.57; per 1-SD increase HR 1.30, 95%CI 1.06–1.59), with similar estimates for PVC. Multi-omics analysis tied high MNP burden to enriched several Streptococcus/Bacteroides species, depleted Ruminococcaceae/Clostridiales taxa, and altered triacylglycerol- and amino acid–related pathways. Mediation analysis indicated that genus GCA-900066575 and triacylglycerol-related metabolites partially mediated MNP-disease progression relationship (q = 0.016 and q = 0.044). Conclusion Elevated serum MNP levels conferred a nearly 3-fold risk of disease progression in CD and mechanistically tied to a unique microbiome-metabolite signature. These findings support serum MNP assessment as a promising environmental marker to refine risk stratification and guide preventive strategies in CD management. References: 1.Estevinho MM, Lodeiro C, Vidal A, et al. Emerging role of environmental pollutants in inflammatory bowel disease risk, outcomes and underlying mechanisms. Gut. 2025;74(3):477-486. doi:10.1136/gutjnl-2024-332523 2.Hu L, Zhao Y, Xu H. Trojan horse in the intestine: a review on the biotoxicity of microplastics combined environmental contaminants. J Hazard Mater. 2022;439:129652. doi:10.1016/j.jhazmat.2022.129652 Conflict of interest: Huang, Lili: No conflict of interest Zheng, Weikai: No conflict of interest Wang, Yejun: No conflict of interest Feng, Shi-Ting: No conflict of interest Li, Xuehua: No conflict of interest
Sign in to start a discussion.
More Papers Like This
Microplastic accumulation in fibrotic intestinal tissue and mesenteric adipose tissue in Crohn’s disease patients
Researchers found microplastic accumulation in intestinal tissue and surrounding fat from Crohn's disease patients, with higher concentrations in areas with more severe scarring and inflammation. Twelve types of microplastics were identified, and frequent invasive medical procedures appeared to worsen the buildup. This is the first study showing that microplastics can penetrate the intestinal barrier in Crohn's patients, raising questions about whether plastic exposure could contribute to disease progression.
P0455 Mucosal Microplastic Deposition is Associated with Disease Severity in Crohn’s Disease: A Pilot Study Using Multi-Modal Imaging and Spectroscopy
Researchers quantified and characterized microplastics in the intestinal mucosa of patients with Crohn's disease compared to healthy controls. The study found that microplastics were present in gut tissue across all groups, but patients with active Crohn's disease had significantly higher concentrations than those in remission or healthy individuals. The findings suggest an association between mucosal microplastic deposition and endoscopic disease severity in Crohn's disease.
Orally Ingested Micro- and Nano-Plastics: A Hidden Driver of Inflammatory Bowel Disease and Colorectal Cancer.
This review synthesizes evidence linking ingested micro- and nano-plastics to inflammatory bowel disease and colorectal cancer risk, proposing that microplastics act as a hidden driver of gut inflammation in vulnerable populations. The authors argue that intestinal accumulation of microplastics triggers immune and oxidative stress pathways that contribute to disease progression.
Analysis of Microplastics in Human Feces Reveals a Correlation between Fecal Microplastics and Inflammatory Bowel Disease Status
Researchers analyzed microplastics in the stool of patients with inflammatory bowel disease (IBD) and healthy volunteers, finding that IBD patients had significantly higher concentrations of microplastics in their feces. PET plastic and polyamide were the most common types found, likely originating from food packaging and dust. The positive correlation between microplastic levels and IBD severity suggests that microplastic exposure may be linked to gut inflammation, though it is not yet clear whether the plastics contribute to the disease or the disease causes more plastic retention.
Analysis\nof Microplastics in Human Feces Reveals a\nCorrelation between Fecal Microplastics and Inflammatory Bowel Disease\nStatus
Researchers found higher concentrations and greater diversity of microplastics in fecal samples from inflammatory bowel disease patients compared to healthy controls, suggesting a potential association between microplastic ingestion and gut inflammation, though causality remains to be established.